INDV
Price
$15.49
Change
+$0.12 (+0.78%)
Updated
Jul 11, 04:59 PM (EDT)
Capitalization
2.91B
13 days until earnings call
MILFF
Price
$0.17
Change
-$0.01 (-5.56%)
Updated
Jul 8 closing price
Capitalization
151.04M
Interact to see
Advertisement

INDV vs MILFF

Header iconINDV vs MILFF Comparison
Open Charts INDV vs MILFFBanner chart's image
Indivior
Price$15.49
Change+$0.12 (+0.78%)
Volume$20.87K
Capitalization2.91B
1CM
Price$0.17
Change-$0.01 (-5.56%)
Volume$200
Capitalization151.04M
INDV vs MILFF Comparison Chart in %
Loading...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MILFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INDV vs. MILFF commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDV is a Hold and MILFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 12, 2025
Stock price -- (INDV: $15.37 vs. MILFF: $0.17)
Brand notoriety: INDV and MILFF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: INDV: 71% vs. MILFF: 23%
Market capitalization -- INDV: $2.91B vs. MILFF: $151.04M
INDV [@Pharmaceuticals: Other] is valued at $2.91B. MILFF’s [@Pharmaceuticals: Other] market capitalization is $151.04M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDV’s FA Score shows that 0 FA rating(s) are green whileMILFF’s FA Score has 0 green FA rating(s).

  • INDV’s FA Score: 0 green, 5 red.
  • MILFF’s FA Score: 0 green, 5 red.
According to our system of comparison, INDV is a better buy in the long-term than MILFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDV’s TA Score shows that 4 TA indicator(s) are bullish while MILFF’s TA Score has 4 bullish TA indicator(s).

  • INDV’s TA Score: 4 bullish, 4 bearish.
  • MILFF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both INDV and MILFF are a good buy in the short-term.

Price Growth

INDV (@Pharmaceuticals: Other) experienced а -0.26% price change this week, while MILFF (@Pharmaceuticals: Other) price change was -17.02% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +56.17%. For the same industry, the average monthly price growth was +5.73%, and the average quarterly price growth was +73.28%.

Reported Earning Dates

INDV is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+56.17% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($2.91B) has a higher market cap than MILFF($151M). INDV YTD gains are higher at: 23.652 vs. MILFF (-11.894). INDV has higher annual earnings (EBITDA): 66M vs. MILFF (-1.15M). INDV has more cash in the bank: 410M vs. MILFF (3.51M). MILFF has less debt than INDV: MILFF (4.11M) vs INDV (282M). INDV has higher revenues than MILFF: INDV (1.09B) vs MILFF (8.11M).
INDVMILFFINDV / MILFF
Capitalization2.91B151M1,925%
EBITDA66M-1.15M-5,730%
Gain YTD23.652-11.894-199%
P/E Ratio2102.00N/A-
Revenue1.09B8.11M13,479%
Total Cash410M3.51M11,698%
Total Debt282M4.11M6,865%
FUNDAMENTALS RATINGS
INDV vs MILFF: Fundamental Ratings
INDV
MILFF
OUTLOOK RATING
1..100
8296
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
58100
SMR RATING
1..100
6180
PRICE GROWTH RATING
1..100
3885
P/E GROWTH RATING
1..100
9997
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MILFF's Valuation (49) in the null industry is somewhat better than the same rating for INDV (100). This means that MILFF’s stock grew somewhat faster than INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (58) in the null industry is somewhat better than the same rating for MILFF (100). This means that INDV’s stock grew somewhat faster than MILFF’s over the last 12 months.

INDV's SMR Rating (61) in the null industry is in the same range as MILFF (80). This means that INDV’s stock grew similarly to MILFF’s over the last 12 months.

INDV's Price Growth Rating (38) in the null industry is somewhat better than the same rating for MILFF (85). This means that INDV’s stock grew somewhat faster than MILFF’s over the last 12 months.

MILFF's P/E Growth Rating (97) in the null industry is in the same range as INDV (99). This means that MILFF’s stock grew similarly to INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDVMILFF
RSI
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
51%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 5 days ago
71%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
74%
Bearish Trend 4 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MILFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGSRX13.05N/A
N/A
JHancock Global Shareholder Yield R2
MSOOX18.52N/A
N/A
MassMutual Small Cap Opps I
WVMIX11.58N/A
N/A
William Blair Mid Cap Value I
HLFZX8.87N/A
N/A
Harding Loevner Frontier Emerg MktsInstZ
REEAX14.98N/A
N/A
RBC Emerging Markets Equity A

MILFF and

Correlation & Price change

A.I.dvisor tells us that MILFF and JUSHF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MILFF and JUSHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MILFF
1D Price
Change %
MILFF100%
N/A
JUSHF - MILFF
7%
Poorly correlated
+35.87%
INDV - MILFF
5%
Poorly correlated
+1.52%
KHTRF - MILFF
3%
Poorly correlated
+1.59%
IPSEY - MILFF
3%
Poorly correlated
N/A
MGWFF - MILFF
3%
Poorly correlated
N/A
More